Sera Prognostics, Inc. (SERA) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
the bull case· 2
44
managers reporting a position in the latest quarterly filings
13fJun 30 '26+1.96%
change in shares held by ten largest reporting managers over latest quarter uptick
13fJun 30 '26the bear case· 2
5
managers whose positions together make up four fifths of the reported value concentrated ownership
13fJun 30 '266 of 24
of the largest reporting managers cut their stake in the latest quarter selling trend
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 11 '26 report. Not a forecast, not advice.
tall tick = annual report · 1 on record
Sera Prognostics, Inc. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 8071, Services-Medical Laboratories, from each company's own filings. Largest first.
SERA (Sera Prognostics, Inc.) has 0 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
Sera Prognostics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services-Medical Laboratories
High 2.11 at 3:45 pm ET, low 2.10 at 2:00 pm ET.
44 managers report a position worth $31.0M between them, and 5 of them hold 80% of it.